Mater Health Services

South Brisbane 4101

0 studies enrolling now · 2 studies all time

What they study most

HER2 Positive Breast Cancer, Ulcerative Colitis

Studies at this site

• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis — Stopped early
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed